Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 152 for “"Chemoresistant"”.
-
Poliovirus Receptor Expression Mimics Clinically Relevant Chemoresistant Ovarian Cancer
… cancer ascites. Finally, knocking out PVR in chemoresistant ovarian cancer led to a restoration in chemosensitity to paclitaxel. These results suggest that strategies targeting the PVR pathway will be advantageous in enhancing anti-tumor immunity in ovarian cancer.
-
The role of epigenetic changes in chemoresistant breast cancer cells
… novel microRNA interactions involved in the chemoresistant phenotype. These three microRNAs displayed depressed expression in the resistant cell lines and we were able to re-establish some level of drug sensitivity through ectopic expression of these under expressed microRNAs. In addition, we …
-
A Screen For Peptides Targeting Chemoresistant Metastatic Triple-Negative Breast Cancer
… develop novel compounds that specifically target chemoresistant cancer metastases. It is based on the hypothesis that metastatic cancer cells express unique cell surface receptors that can be targeted. To test this hypothesis, we performed a combinatorial phage-displayed peptide library screen to …
-
Targeting LEDGF/p75 to Sensitize Chemoresistant Prostate Cancer Cells to Taxanes
Prostate cancer (PCa) is the second most diagnosed cancer in males. This disease disproportionately affects African American men, with a higher incidence and mortality compared to other ethnic/racial groups. An aging male population and the complexity of addressing the health disparities associated …
-
ALPHA-PARTICLE NANOTHERAPEUTICS AGAINST METASTATIC AND/OR CHEMORESISTANT TRIPLE NEGATIVE BREAST CANCER
… part of this dissertation. Importantly, the chemoresistant cell line, CR-MDA-MB-436 exhibited similar sensitivity to alpha-particle emitters as the native chemosensitive TNBC cell lines. Our findings, in the second part of this dissertation, demonstrated the potential of a general, diffusion- …
-
The response of chemoresistant human colorectal cancer cells HCT116 to cytotoxic treatment /
… for the response of human CRC cells HCT116 and chemoresistant sublines HCT116/FU (generated by cell cultivation with 5-fluorouracil, hereafter 5-FU), HCT116/OXA (generated by cell cultivation with oxaliplatin, hereafter OxaPt) to cytotoxic treatment was investigated. In monolayer cell culture …
-
The Role and Regulation of the Phosphatase PPM1D in Chemoresistant Gynecological Cancers
Cisplatin (CDDP; cis-diamminedichloroplatinum) resistance presents a major impediment in the treatment of several gynecologic solid tumors, including ovarian and cervical tumors. p53, a critical regulator of cellular apoptosis, is a determinant of CDDP sensitivity. In our study, we have observed …
-
Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities
… focusses on the characterization of the in vivo chemoresistant human hepatocellular carcinoma HUH-REISO established from a metronomically cyclophosphamide (CPA) treated HUH7 xenograft mouse model. First step of the work was the establishment of the xenograft mouse model. SCID mice bearing …
-
Characterizing chromosome instability in chemonaïve, chemosensitive and chemoresistant high-grade serous ovarian cancer
… progression and will increase in recurrent and chemoresistant disease. Using a combination of quantitative imaging microscopy and cytogenetic approaches, I investigate the prevalence and unique temporal dynamics of CIN in ascites derived patient samples and solid tumor samples collected from …
-
Radiation responses of chemoresistant adenocarcinoma cells : from molecular mechanisms to new reversal strategies
Breast cancer is a major cause of cancer-related death among women throughout the world. Treatment of breast cancer often fails due to the development of resistance to both chemo- and radiotherapy. The aim of this study was to analyze and compare the response to radiation of MCF-7 breast …
-
Tissue Transglutaminase (TG2) is a potential therapeutic target in the treatment of chemoresistant breast cancer
… key player in the progression and metastasis of chemoresistant breast cancer. One of the foremost survival signalling pathways implicated in causing drug resistance in breast cancer is the constitutive activation of NFκB (Nuclear Factor -kappa B) induced by TG2. This study provides a mechanism by …
-
NEW PREDICTIVE FACTORS IDENTIFIED BY MOLECULAR STUDY IN CHEMORESISTANT HUMAN AND CANINE MAMMARY CARCINOMA CELLS
Mammary disorders in dogs occur very frequently in non-neutered and older animals. The majority of these tumors are classified as malignant and the occurrence of metastases in lymph nodes and distant organs can reach 30% of all cases. Canine mammary tumors (CMTs) share similarities with women’s …
-
Establishment and characterisation of chemoresistant osteosarcoma cell lines by single and multi-agent induced strategies
… cancer cells. In this study, clinically relevant chemoresistant osteosarcoma cell models were developed from the cell lines MG-63 and HOS-143B. One of the strategies used the current study includes a multiple drugs combination approach, where cisplatin, doxorubicin, and methotrexate are combined …
-
Harnessing The Pro-Apoptotic Function Of Myc To Improve Therapeutic Responses In Chemoresistant B-Cell Lymphoma
Therapeutic targeting of initiating oncogenes is the mainstay of precision medicine. Considerable efforts have been expended toward silencing MYC, which drives many human cancers including Burkitt lymphomas (BL). Yet, the effects of MYC silencing on standard-of-care therapies are poorly understood. …
-
Phenotypic Profiling of Colon Tumor Organoid Monolayers Characterizes a FOLFOX-Induced, AKT-Driven Subpopulation of Chemoresistant Cells
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the US as well as the third most common cause of cancer-related death. Standard treatment includes surgical resection and adjuvant chemotherapy with multidrug regimens such as FOLFOX (Folinic Acid, 5-Fluorouracil, Oxaliplatin). …
-
Biomarker study in malignant peritoneal mesothelioma (MPM) with therapeutic investigations using bromelain and N-acetyl cysteine on chemoresistant MPM cells
… to tumour cells, is highly expressed in chemoresistant MPM cells (YOU and PET). Since, Bromelain and N-Acetyl Cysteine (NAC) are glycolytic agents, we investigated their anti-tumour effect on MPM cells. METHODS Patient samples were screened, using immunohistochemistry, for the expression …
Page 1 of 8